Latest news on Alzheimer's
Check out the latest news about Alzheimer's disease research that we carry out at the Barcelonaβeta Brain Research Center (BBRC). Discover the advances in Alzheimer's prevention in which our scientists participate, as well as the news of the Alfa Study, dedicated to the early detection and prevention of the disease.
Increasing physical activity in middle age may protect against alzheimer's disease
The study, published in the journal Alzheimer’s & Dementia, involved 337 people from the ALFA longitudinal cohort of the Barcelonaβeta Brain Research Center (BBRC), with the support of the “la Caixa” Foundation.
We investigate, we move forward: the 2024 Impact Report is now available
In this document we collect the most notable activity of 2024, a year of key scientific advances and new strategic alliances that consolidate a change in the approach to Alzheimer's disease
Dr. Sandra Acosta leads a new research group at the Barcelonaβeta Brain Research Center to study alzheimer’s progression
The group will work with three-dimensional cellular models (organoids) that replicate the structure of the human brain to study the origin and progression of diseases such as Alzheimer’s.
The European Commission approves lecanemab for the treatment of early-stage Alzheimer's disease
This approval is a key step forward in the development of treatments that target the biological mechanisms of Alzheimer's disease.
A blood test for early detection of Alzheimer's disease
A study involving more than 1,700 people from five hospitals in Barcelona, Sweden and Italy has validated the usefulness of a biomarker in blood to detect Alzheimer's disease in the clinical setting.
We participate once again in the AD/PD 2025
BBRC researchers share key advances in Alzheimer's and neurosciences in the framework of the AD/PD 2025.
The EMA issues a negative opinion on the authorization of donanemab for the treatment of Alzheimer's disease
Donanemab, approved in the US and other countries, fails to get approval in Europe due to concerns about its adverse effects
Study reveals gender inequalities in participation in clinical trials for Alzheimer’s disease prevention
The study highlights the need to adapt recruitment strategies to existing gender differences to ensure equitable representation in research.
New study compares plasma biomarkers for detecting Alzheimer’s disease in memory clinics
The findings revealed that plasma p-tau biomarkers demonstrated superior accuracy in detecting Alzheimer’s compared to other biomarkers
